Insight

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

Federica Ferrario/LinkedIn

Nov 3, 2024, 16:19

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

Federica Ferrario, Radiation Oncology Resident at the University of Milan, shared a post on X about a recent paper by Riccardo Ray Colciago et al. published in Current Oncology.

“Our real-world analysis on SBRT and oligoprogressive Lung Cancer is officially published and open access! TTNT 8 months saves.

Amazing team effort: Riccardo Ray Colciago, Chiara Chissotti, Maria Belmonte, Valeria Faccenda, Denis Panizza, Stefano Arcangeli.”

“Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer”

Authors: Riccardo Ray Colciago, Chiara Chissotti, Federica Ferrario, Diego Luigi Cortinovis, Stefano Arcangeli et al.

Federica Ferrario: Our real-world analysis on SBRT and oligoprogressive Lung Cancer

cancer Chiara Chissotti Denis Panizza Federica Ferrario Lung cancer Maria Belmonte OncoDaily Oncology Riccardo Ray Colciago SBRT Stefano Arcangeli Valeria Faccenda

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer